Next in our top 10 of 2021, we look back at how automation, self-administration, and more are shifting capital investments.
Three out of four pharmaceutical and medical device respondents say their companies are looking to make capital investments in the next 12-24 months, either to refurbish their old tooling or to purchase new equipment, according to a new report by PMMI Business Intelligence. These decisions will be driven by technology, automation and regulation, as well as by cost and ROI. Regulations and disruptions due to COVID-19 have also driven demand for innovative, advanced equipment.
